|
HNRNPA3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.932400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.975000E-01 |
| Normal-vs-Stage2 |
5.338200E-02 |
| Normal-vs-Stage3 |
1.804860E-03 |
| Normal-vs-Stage4 |
1.652400E-02 |
| Stage1-vs-Stage2 |
1.134390E-01 |
| Stage1-vs-Stage3 |
2.742100E-03 |
| Stage1-vs-Stage4 |
4.504300E-02 |
| Stage2-vs-Stage3 |
6.074200E-01 |
| Stage2-vs-Stage4 |
9.512400E-01 |
| Stage3-vs-Stage4 |
5.895200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.203600E-02 |
| Normal-vs-AfricanAmerican |
1.051960E-01 |
| Normal-vs-Asian |
9.793600E-02 |
| Caucasian-vs-AfricanAmerican |
9.964600E-01 |
| Caucasian-vs-Asian |
8.303000E-03 |
| AfricanAmerican-vs-Asian |
1.979900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.059900E-03 |
| Normal-vs-Female |
4.074600E-01 |
| Male-vs-Female |
4.701000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.105600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.217170E-01 |
| Normal-vs-Age(61-80Yrs) |
1.423830E-02 |
| Normal-vs-Age(81-100Yrs) |
1.074030E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.409800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.124600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.597700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.039600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.404200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.327780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.952100E-02 |
| Normal-vs-Grade 2 |
4.362400E-01 |
| Normal-vs-Grade 3 |
6.351600E-04 |
| Normal-vs-Grade 4 |
1.385640E-02 |
| Grade 1-vs-Grade 2 |
4.064500E-02 |
| Grade 1-vs-Grade 3 |
2.030200E-04 |
| Grade 1-vs-Grade 4 |
3.461000E-03 |
| Grade 2-vs-Grade 3 |
4.778400E-04 |
| Grade 2-vs-Grade 4 |
2.269800E-02 |
| Grade 3-vs-Grade 4 |
9.656200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.817400E-01 |
| Normal-vs-ccB subtype |
2.849300E-04 |
| ccA subtype-vs-ccB subtype |
5.82150000427717E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.100260E-02 |
| Normal-vs-N1 |
7.560300E-02 |
| N0-vs-N1 |
5.494800E-01 |
|
|
